Merck Serono Announces New Publication of Results of the Phase III START Trial Investigating Tecemotide in Non-Small Cell Lung Cancer in The Lancet Oncology
Darmstadt, Germany (ots/PRNewswire) - - Publication offers detailed results of START, including an exploratory analysis of the clinically meaningful survival prolongation with tecemotide maintenance therapy in a predefined subgroup of patients treated with concurrent chemoradiotherapy - As previously announced Merck ...